Growth and telomerase inhibition of SK-MEL 28 melanoma cell line by a plant flavonoid, apigenin

Journal of Biochemistry and Molecular Biology

Volumn 31, Issue 4, 1998, Pages 339-344

  Kang, Sang Sun ^a   Lim, Seung Eun ^a  

^a Shin Dong Bang R and D Center   (South Korea)

Author keywords

Apigenin; Apoptosis; Telomerase

Indexed keywords

EID: 3042911716     PISSN: 12258687     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Baek, J. H., Kang, C. M., Chung, H. Y., Park, M. H. and Kim, K. W. (1996) Increased expression of c-jun in the bile acid-induced apoptosis in mouse F9 teratocarcinoma stem cells. J. Biochem. Mol. Biol. (formerly Korean Biochem. J.) 29, 68-72.
2. Bestilny, L. J., Brown, C. B., Miura, Y., Robertson, L. D. and Riabowol, K. T. (1996) Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines. Cancer Res. 56, 3796-3802.
3. Birt, D. F., Mitchell, D., Gold, B., Pour, P. and Pinch, H. C. (1997) Inhibition of ultraviolet light induced skin carcinogenesis in SKH-1 mice by apigenin, a plant flavonoid. Anticancer Res. 17, 85-91.
4. Brandi, M. L. (1997) Natural and synthetic isoflavones in the prevention and treatment of chronic diseases. Calcif. Tissue Int. 61 (Suppl. 1), S5-S8.
5. Brown, J. P., Nishiyama, K., Hellstrom, I. and Hellstrom, K. E. (1981) Structural characterization of human-melanoma-associated antigen p97 with monoclonal antibodies. J. Immunol. 127, 539-546.
6. Fotsis, T., Pepper, M. S., Aktas, E., Breit, S., Rasku, S., Adlercreutz, H., Wahala, K., Montesano, R. and Schweigerer, L. (1997) Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res. 57, 2916-2921.
7. Holt, S. E., Wright, W. E. and Shay, J. W. (1996) Regulation of telomerase activity in immortal cell lines. Mol. Cell. Biol. 16, 2932-2939.
8. Kang, S. S. and Folk, W. R. (1992) Lymphotropic papovavirus transforms hamster cells without altering the amount or stability of p53. Virology 191, 754-764.
9. Kaufmann, W. K. (1998) Human topoismerase II function, tyrosine phosphorylation and cell cycle checkpoints. Pro. Soc. Exp. Bio. Med. 217, 327-334.
10. Kennedy, A. R. (1995) The evidence for soybean products as cancer preventive agents. J. Nutr. 125 (Suppl. 3), S733-S743.
11. Kim, N. W. and Wu, F. (1997) Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res. 25, 2595-2597.
12. Kim, T. U., Yang, S. H. and Kim, S. K. (1996) Cytotoxic and apoptotic effects of echinomycin on murine leukemia cells. J. Biochem. Mol. Biol. (formerly Korean Biochem. J.) 29, 489-493.
13. Klein, M., Weissenbock, G., Dufaud, A., Gaillard, C., Kreuz, K. and Martinoia, E. (1996) Different energization mechanisms drive the vacuolar uptake of a flavonoid glucoside and a herbicide glucoside. J. Biol. Chem. 271, 29666-29671.
14. Krasagakis, K., Garbe, C. and Orfanos, C. E. (1993) Cytokines in human melanoma cells: synthesis, autocrine stimulation and regulatory functions - an overview. Melanoma Res. 3, 425-433.
15. Kuo, M., L. and Yang, N. C. (1996) Reversion of v-H-ras-transformed NIH 3T3 cells by apigenin through inhibiting mitogen activated protein kinase and its downstream oncogenes. Biochem. Biophys. Res. Commun. 1212, 767-775.
16. Lee, M. H., Park, S. H., Song, H. S., Lee, K. H. and Park, J. S. (1997) A 100 kDa protein binding to bHLH family consensus recognition sequence of rat p53 promoter. J. Biochem. Mol. Biol. (formerly Korean Biochem. J.) 30, 205-211.
17. Lepley, D. M., Li, B., Birt, D. F. and Pelling, J. C. (1996) The chemopreventive flavonoid apigenin induces G2/M arrest in keratinocytes. Carcinogenesis 17, 2367-2375.
18. Lepley, D. M. and Pelling, J. C. (1997) Induction of p21/WAF1 and G1 cell-cycle arrest by the chemopreventive agent apigenin. Mol. Carcinog. 19, 74-82.
19. Levine, A. J. (1997) p53, the cellular gatekeeper for growth and division. Cell 88, 323-331.
20. Li, H., Zhao L. L., Funder J. W. and Liu, J. P. (1997) Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells. J. Biol. Chem. 272, 16729-16732.
21. Plaumann, B., Fritsche, M., Rimpler, H., Brandner, G. and Hess, R. D. (1996) Flavoniods activate wild-type p53. Oncogene 13, 1605-1614.
22. Rauth S., Kichina J. and Green A. (1997) Inhibition of growth and induction of differentiation of metastatic melanoma cells in vitro by genistein: chemosensitivity is regulated by cellular p53. Br. J. Cancer 75, 1559-1566.
23. Record, I. R., Broadbent J. L., King, R. A., Dreosti, I. E., Head, R. J. and Tonkin, A. L. (1997) Genistein inhibits growth of B16 melanoma cells in vivo and in vitro and promotes differentiation in vitro. Int. J. Cancer. 72, 860-864.
24. Rhyu, M. S. (1995) Telomerase, telomerase, and immortality. J. Natl. Cancer Inst. 87, 884-894.
25. Shih, I. M. and Herlyn, M. (1994) Autocrine and paracrine roles for growth factors in melanoma. In Vivo 8, 113-123.
26. Stoll, B. A. (1997) Eating to beat breast cancer: potential role for soy supplements. Ann. Oncol. 8, 223-225.